Lenalidomide

Brand name: Revlimid is a chemotherapy drug used to treat plasma cell myeloma and myelodysplastic syndromes (MDS), specifically in patients with deletion 5q with or without additional cytogenetic abnormalities. Side effects include marrow toxicity resulting in neutropenia and thrombocytopenia.